Is There an Association Between Clinical Presentation and the Location and Extent of Myocardial Involvement of Cardiac Sarcoidosis as Assessed by 18 F- Fluorodoexyglucose Positron Emission Tomography? | Zendy

Brian A. Mc Ardle | Zendy; David H. Birnie | Zendy; Ran Klein | Zendy; Rob A. de Kemp | Zendy; Eugene Leung | Zendy; Jennifer M. Renaud | Zendy; Jean N. DaSilva | Zendy; George A. Wells | Zendy; Rob Beanlands | Zendy; Pablo B. Nery | Zendy

Open Access

Is There an Association Between Clinical Presentation and the Location and Extent of Myocardial Involvement of Cardiac Sarcoidosis as Assessed by ¹⁸ F- Fluorodoexyglucose Positron Emission Tomography?

Author(s) -

Brian A. Mc Ardle,

David H. Birnie,

Ran Klein,

Rob A. de Kemp,

Eugene Leung,

Jennifer M. Renaud,

Jean N. DaSilva,

George A. Wells,

Rob Beanlands,

Pablo B. Nery

Publication year - 2013

Publication title -

circulation cardiovascular imaging

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.584

H-Index - 99

eISSN - 1942-0080

pISSN - 1941-9651

DOI - 10.1161/circimaging.112.000289

Subject(s) - medicine , nuclear medicine , positron emission tomography , sarcoidosis , standardized uptake value , receiver operating characteristic , ventricular tachycardia , cardiac sarcoidosis

Positron emission tomography using (18)F-Fluorodeoxyglucose (FDG) is an emerging modality for diagnosis of cardiac sarcoidosis (CS). We compared the location and degree of FDG uptake in CS patients presenting with either advanced atrioventricular block (AVB) or ventricular tachycardia (VT).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research